A detailed history of Eagle Health Investments LP transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Eagle Health Investments LP holds 43,200 shares of LNTH stock, worth $4.75 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
43,200
Previous 43,200 -0.0%
Holding current value
$4.75 Million
Previous $2.69 Million 29.02%
% of portfolio
0.61%
Previous 0.5%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$55.6 - $77.89 $20.8 Million - $29.1 Million
-373,500 Reduced 89.63%
43,200 $2.68 Million
Q3 2023

Oct 27, 2023

BUY
$60.27 - $90.75 $9.85 Million - $14.8 Million
163,500 Added 64.57%
416,700 $29 Million
Q2 2023

Aug 14, 2023

SELL
$82.41 - $99.65 $2.6 Million - $3.15 Million
-31,600 Reduced 11.1%
253,200 $21.2 Million
Q1 2023

May 12, 2023

BUY
$47.76 - $82.86 $13.6 Million - $23.6 Million
284,800 New
284,800 $23.5 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.55B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Eagle Health Investments LP Portfolio

Follow Eagle Health Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Health Investments LP with notifications on news.